Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

37,358 stories, page 205 of 623

Advanced search

🌍Aug 22discoverynews.google.comTier 3 · Aggregated media

Moderna (MRNA) Cancer Vaccine Success Won’t Lift All mRNA Stocks

Barron'sOriginal source

🌍Aug 22discoverynews.google.comTier 3 · Aggregated media

Biotech Led Healthcare Higher As Deal News Rolled In

FinimizeOriginal source

🌍Aug 22discoverynews.google.comTier 3 · Aggregated media

Trinity Biotech (NASDAQ: TRIB) ends $25M standby share deal

Stock TitanOriginal source

🌍Aug 22discoverynews.google.comTier 3 · Aggregated media

Pharmacist-led menopause clinics improve women’s knowledge and confidence

The Pharmaceutical JournalOriginal source

🌍Aug 22discoverynews.google.comTier 3 · Aggregated media

Survey warns of ‘lifestyle drive’ for weight-loss medication

The Pharmaceutical JournalOriginal source

🌍Aug 22discoverynews.google.comTier 3 · Aggregated media

Why Scientists Say This Personalized Cancer Vaccine Could Be a Game-Changer

National GeographicOriginal source

🌍Aug 22discoverynews.google.comTier 3 · Aggregated media

Amplitude Therapeutics Partners with Eli Lilly | PharmExec

Pharmaceutical ExecutiveOriginal source

🇺🇸Aug 22CROadvarra.comTier 2 · Direct publisher

What Is the Difference Between an SAE, AE, and UADE in Clinical Trials?

Advarra (IRB)Original source

🌍Aug 22discoverynews.google.comTier 3 · Aggregated media

Little-Known HOWL Stock Skyrockets 100% on Biotech Merger News

inklOriginal source

🌍Aug 22discoverynews.google.comTier 3 · Aggregated media

FDA Approves Pasatru for Rare Bone-Forming Disorder

LabrootsOriginal source

🌍Aug 22discoverynews.google.comTier 2 · Trade media

Intismeran autogene a turning point for cancer vaccines

Pharmaceutical TechnologyOriginal source

🌍Aug 22discoverynews.google.comTier 3 · Aggregated media

Before its recent Phase 3 LSD win, Definium modeled up to $70,000 a year for a therapy that could fill a clinical shift

drugdiscoverytrends.comOriginal source

🌍Aug 22Researchuab.eduTier 2 · Direct publisher

UAB and Children’s of Alabama celebrate five-year anniversary of NICU Bookworms program

University of Alabama at BirminghamOriginal source

🌍Aug 22discoverynews.google.comTier 3 · Aggregated media

Archimedes Center opens biotech lab for young scientists in Henrietta

YahooOriginal source

🌍Aug 22discoverynews.google.comTier 3 · Aggregated media

Why Werewolf Therapeutics stock exploded higher and what comes next?

InvezzOriginal source

🌍Aug 22discoverynews.google.comTier 3 · Aggregated media

This news-style clip explains the evolution of mRNA technology from its well-known application in COVID-19 vaccines to its original purpose: personalized cancer treatment. It focuses on recent positive Phase 3 trial results from Moderna and Merck for a melan

facebook.comOriginal source

🌍Aug 22discoverynews.google.comTier 3 · Aggregated media

Weighing the pros and cons of participating in a clinical trial

amyloidosisnewstoday.comOriginal source

🌍Aug 22discoverynews.google.comTier 3 · Aggregated media

Arcutis-Backed Phase 3 ZORYVE Foam Study Targets Growth in Seborrheic Dermatitis

TipRanksOriginal source

🌍Aug 22discoverynews.google.comTier 3 · Aggregated media

Kodiak Sciences Advances ALTO Phase 3 Trial In Diabetic Eye Disease

TipRanksOriginal source

🌍Aug 22discoverynews.google.comTier 3 · Aggregated media

GSK’s New Phase 3 Asthma Trial Sets the Stage for the Next Wave in Respiratory Growth

TipRanksOriginal source

🌍Aug 22discoverynews.google.comTier 3 · Aggregated media

Early-Stage HH160 Cancer Trial Puts BeOne Medicines on Long-Term Investors’ Radar

TipRanksOriginal source

🌍Aug 22discoverynews.google.comTier 3 · Aggregated media

Strong Merck stock trades close to its 52-week high as analysts lift targets after melanoma trial wi

Ad-hoc-news.deOriginal source

🌍Aug 22discoverynews.google.comTier 3 · Aggregated media

Pittsburgh biotech firm pivots to provide AI compute, reports $317M in prepayments

The Business JournalsOriginal source

🌍Aug 22discoverynews.google.comTier 3 · Aggregated media

Moderna’s AI-Designed mRNA Melanoma Vaccine Succeeds in Phase 3 Trial

hypefresh.comOriginal source

🌍Aug 22discoverynews.google.comTier 3 · Aggregated media

CRBP’s CRB-701 Phase 3 Trial Sets the Stage for a Key Oncology Catalyst

The Globe and MailOriginal source

🌍Aug 22discoverynews.google.comTier 3 · Aggregated media

BioMarin Pharmaceutical (BMRN) Beat Q2 Expectations, Is The Recent Re Rating Already Priced In?

simplywall.stOriginal source

🌍Aug 22discoverynews.google.comTier 3 · Aggregated media

Larimar’s Phase 3 Friedreich’s Ataxia Trial Puts Nomlabofusp in the Investor Spotlight

TipRanksOriginal source

🌍Aug 22discoverynews.google.comTier 3 · Aggregated media

IOVA Stock Pulls Back As Biotech Momentum Cools

StocksToTradeOriginal source

🌍Aug 22discoverynews.google.comTier 3 · Aggregated media

Book value per share of ONO Pharmaceutical Co., Ltd. – HAM:ON4

TradingViewOriginal source

🌍Aug 22discoverynews.google.comTier 3 · Aggregated media

ABUS Stock Pops As Moderna Windfall Resets Biotech Balance Sheet

timothysykes.comOriginal source

🌍Aug 22discoverynews.google.comTier 3 · Aggregated media

FDA suspends food license of Bombay Presidency Radio Club due to severe safety and hygiene violations

ANI NewsOriginal source

🌍Aug 22discoverynews.google.comTier 3 · Aggregated media

When PV Infrastructure Fails, Commercial Launches Pay the Price

Pharmaceutical CommerceOriginal source

🌍Aug 22discoverynews.google.comTier 3 · Aggregated media

Ultragenyx: Progress Is Real, But Profitability Is The Real Test (Rating Upgrade)

Seeking AlphaOriginal source

🌍Aug 22discoverynews.google.comTier 3 · Aggregated media

Three Biotech Stocks Stick Out With Their Stellar Charts

Investor's Business DailyOriginal source

🌍Aug 22discoverynews.google.comTier 3 · Aggregated media

Biotech Stocks To Consider - August 21st

MarketBeatOriginal source

🌍Aug 22discoverynews.google.comTier 3 · Aggregated media

EyeWorld Weekly, August 21, 2026

EyeWorldOriginal source

🌍Aug 22discoverynews.google.comTier 3 · Aggregated media

Former Athira CEO returns to Seattle biotech scene with Kirkland company

The Business JournalsOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Unhandcuff America’s Biotech Innovators to Beat China

RealClearHealthOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Top AI Trends Transforming Healthcare Economics

Investing News NetworkOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

China Resources Pharmaceutical Says H1 Net Profit Attributable For Tasly Pharmaceutical RMB892.7 Mln

TradingViewOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Rare disease drug Tavneos recalled in Republic of Ireland

BBCOriginal source

🇺🇰Aug 21Regulatorygov.ukTier 1 · Regulatory source

Department of Health and Social Care record of processing activity (RoPA)

The record of processing activity lists the personal data being held and processed by the Department...

UK Department of Health and Social CareOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

65,000 Patients a Year, Zero Approved Drugs, One Phase 3 Trial

The Globe and MailOriginal source

🌍Aug 21discoverynews.google.comTier 2 · Trade media

Chronic pain biotech co-founded by Vivek Ramaswamy joins reverse merger train

Endpoints NewsOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Kratom Component in Clinical Trial for Opioid Use Disorder

Psychiatric TimesOriginal source

🇨🇭Aug 21Industryinterpharma.chTier 1 · Company source

Medienmitteilung: Ein wichtiges Signal für Schweizer Patientinnen und Patienten

Interpharma SwitzerlandOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

2 of 3 canteens ran without licences: Maharashtra FDA chief Tukaram Mundhe on Bombay HC raid

India TodayOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Moderna Stock Is Just The Start: Why AI-Focused Money Might Flow Into Biotech

Investor's Business DailyOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Tempus AI Stock Climbs Friday: What's Driving the Move?

TradingViewOriginal source

🌍Aug 21discoverynews.google.comTier 2 · Trade media

Lawmakers urge FDA to enact new China policies after 3 gene therapy deaths

BioSpaceOriginal source

🌍Aug 21discoverynews.google.comTier 2 · Trade media

Werewolf and Ambros to tie the knot in $150M rare disease deal

BioSpaceOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

The Trump Administration Advisor Set to Become Next FDA Lead

Drug TopicsOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Hello, Biotech. AI Will See You Now.

Investor's Business DailyOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Kangmei Pharmaceutical leadership shakeup: Lai Zhijian steps down 18 months early; He Jigong's former factory head Meng Jun takes over party committee

finance.biggo.comOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA suspends licenses of Radio Club, McDonald's outlet in south Mumbai

The New Indian ExpressOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Weekly Buzz: RARE, REGN Secure FDA Nod, BMRN Stikes Deal; HUMA, EYPT Face Trial Setbacks

RTTNewsOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Merck & Co Inc Stock (MRK) Moved Up by 3.41% on Aug 21: Facts Behind the Movement

TradingKeyOriginal source

🌍Aug 21Industrydarnytsia.uaTier 3 · Secondary coverage

Cough & cold

Darnitsa (Ukraine)Original source

🌍Aug 21Industrydarnytsia.uaTier 3 · Secondary coverage

Pain management

Darnitsa (Ukraine)Original source

🌍Aug 21Industrydarnytsia.uaTier 3 · Secondary coverage

Neurology

Darnitsa (Ukraine)Original source